相关实验视频
Updated: May 25, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.8K
多种机器学习方法的整合开发了一个基于基因突变的分类器,用于准确的免疫治疗结果
Run Shi1, Jing Sun2,3, Zhaokai Zhou4
1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
NPJ precision oncology
|February 26, 2025
概括
预测癌症免疫检查点阻塞 (ICB) 反应至关重要. 这项研究使用机器学习开发了一种基于基因突变的新型预测签名 (GPS),其性能优于现有的方法,用于准确的患者分层和改善结果.
科学领域:
- 计算生物学和生物信息学
- 癌症免疫学和免疫疗法
- 基因组学和精准医学精准医学
背景情况:
- 目前用于免疫检查点阻塞 (ICB) 反应的生物标志物,如PD-(L) 1表达和瘤突变负担 (TMB),具有局限性.
- 对于癌症患者的ICB治疗更可靠的预测方法非常需要.
- 机器学习方法提供了从基因组数据中识别新型预测签名的潜力.
研究的目的:
- 使用机器学习识别与ICB反应显著相关的关键非同义突变.
- 开发和验证一种新的分类器,即基于基因突变的预测签名 (GPS),用于预测ICB反应.
- 根据GPS分类来研究瘤免疫性,免疫反应和瘤微环境 (TME).
主要方法:
- 将多个机器学习算法应用于非同义突变数据,以确定预测特征.
- 开发了基于基因突变的预测签名 (GPS) 分类器,用于根据预测的ICB反应对患者进行分类.
- 在独立患者队列中使用多奥米克分析,多重免疫组织化学 (mIHC) 和ex-vivo有机共同培养模型验证了GPS性能.
主要成果:
- 通过机器学习分析,确定了与ICB反应密切相关的关键突变.
- 开发的GPS分类器在独立验证队伍中,与传统预测器相比,表现优越.
- 多组和mIHC分析显示,在肺腺癌 (LUAD) 的不同GPS组中,瘤免疫性和TME特征明显.
- 实体模型证实了GPS定义的患者样本对ICB治疗的差异反应.
结论:
- 基因突变基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
- GPS提供了一个有前途的工具,可以改善患者选择ICB治疗,从而降低成本和测试时间.
- 这种方法促进了癌症免疫治疗中的临床实施和个性化治疗策略.
更多相关视频
相关概念视频
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

